Graft Polymer’s Initial Public Offering

In UK Hill Dickinson, Memery Crystal, advised on the matter.

Hill Dickinson advised Turner Pope Investments Ltd with a team including James Paton-Philip (Picture – Equity Capital Markets).

Memery Crystal advised Graft Polymer with a team including Nick Davis (Equity Capital Markets).

Graft Polymer (UK) plc has been admitted to trading on the standard list of the main market of the London Stock Exchange together with a £5 million fundraise.

Established in 2017 by a group of polymer technology experts and venture capitalists, Graft Polymer’s core business comprises polymer modification and development of drug delivery systems.

The group is a highly innovative business with strong intellectual property, holding several patent applications. The fundraising of £5 million is to fund accelerated growth, expand the group’s research and production facility in Slovenia to meet rising customer demand, upgrade existing facilities to enable future IP registration, and increase both inventory and marketing opportunities following expected increased sales.

Graft Polymer’s shares were admitted to trading on 6 January 2022, with the ticker ‘LSE:GPL’ and a market capitalisation on admission of £22.4 million. The listing is the first on the main market of the London Stock Exchange in 2022. 

Hill Dickinson legal director Sam Hudson and partner James Paton-Philip (Picture) led on the transaction, with support from trainee solicitor Amelia Chung and paralegals Mariam El-Mir and Oliver Hart.

The Memery Crystal team on this deal was led by our senior ECM partner Nick Davis and senior associate Robert Black, who were assisted by solicitor Hannah Maxwell and paralegal Priya Morzeria. 

Involved fees earner: Sam Hudson – Hill Dickinson; James Paton-Philip – Hill Dickinson; Robert Black – Memery Crystal; Nick Davis – Memery Crystal; Hannah Maxwell – Memery Crystal;

Law Firms: Hill Dickinson; Memery Crystal;

Clients: Graft Polymer; Turner Pope Investments Ltd;

Author: Giulia Di Palma